WHO-CHOICE Interventions
Tuberculosis
| CODE | DESCRIPTION | COVERAGE |
| TB-1 | SmearPos: Treatment of new smear-positive cases only under DOTS | 50% |
| TB-2 | SmearPosNeg: As for SmearPos, plus treatment of smear-negative cases under DOTS | 50% |
| TB-3 | SmearPosMDR: As for SmearPos, plus DOTS-plus treatment involving use of an 18 month regimen including first and second-line drugs for patients that have already failed treatment with the short-course first-line regimens and are found to have MDR | 50% |
| TB-4 | Combination: As SmearPos, plus DOTS treatment of smear-negative cases plus DOTS-plus standardized second-line drug re-treatment as defined in Intervention 3 | 50% |
| TB-5 | SmearPos: Treatment of new smear-positive cases only under DOTS | 80% |
| TB-6 | SmearPosNeg: As for SmearPos, plus treatment of smear-negative cases under DOTS | 80% |
| TB-7 | SmearPosMDR: As for SmearPos, plus DOTS-plus treatment involving use of an 18 month regimen including first and second-line drugs for patients that have already failed treatment with the short-course first-line regimens and are found to have MDR | 80% |
| TB-8 | Combination: As SmearPos, plus DOTS treatment of smear-negative cases plus DOTS-plus standardized second-line drug re-treatment as defined in Intervention 3 | 80% |
| TB-9 | SmearPos: Treatment of new smear-positive cases only under DOTS | 95% |
| TB-10 | SmearPosNeg: As for SmearPos, plus treatment of smear-negative cases under DOTS | 95% |
| TB-11 | SmearPosMDR: As for SmearPos, plus DOTS-plus treatment involving use of an 18 month regimen including first and second-line drugs for patients that have already failed treatment with the short-course first-line regimens and are found to have MDR | 95% |
| TB-12 | Combination: As SmearPos, plus DOTS treatment of smear-negative cases plus DOTS-plus standardized second-line drug re-treatment as defined in Intervention 3 | 95% |